Implantable cardioverter-defibrillator implantation for primary and secondary prevention: indications and outcomes

By  

Cardiology in the Young, Vol. 27, Iss. S1, 2017-01 ,pp. : S126-S131

Cambridge University Press

Access to resources Recommend Favorite

Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation

By Nazmul Mohammed N.   Cha Yong-Mei   Lin Grace   Asirvatham Samuel J.   Powell Brian D.  

EP-Europace, Vol. 15, Iss. 3, 2013-03 ,pp. : 409-413

Oxford University Press

Access to resources Recommend Favorite

Efficacy and safety of nitroglycerin for preventing venous spasm during contrast-guided axillary vein puncture for pacemaker or defibrillator leads implantation

By Duan Xu   Ling Feng   Shen Yun   Yang Jun   Xu Hai-ying   Tong Xiao-shan  

EP-Europace, Vol. 15, Iss. 4, 2013-04 ,pp. : 566-569

Oxford University Press

Access to resources Recommend Favorite

Infections associated with permanent pacemakers and implanted cardioverter–defibrillator devices. A 10-year regional study in Denmark

By Smit Jesper   Korup Eva   Schønheyder Henrik C.  

Scandinavian Journal of Infectious Diseases, Vol. 42, Iss. 9, 2010-09 ,pp. : 658-664

Informa Healthcare

Access to resources Recommend Favorite

Sleep-disordered breathing in patients with implantable cardioverter-defibrillator

By Grimm Wolfram   Apelt Sandra   Timmesfeld Nina   Koehler Ulrich  

EP-Europace, Vol. 15, Iss. 4, 2013-04 ,pp. : 515-522

Oxford University Press

Access to resources Recommend Favorite